S-1/A: Encore Medical Files S-1/A Amendment, Adds Investor Warrant
Registration Statement Amendment
Encore Medical, Inc. has filed an S-1/A amendment to its registration statement, primarily to include Exhibit 4.3, the Form of Investor's Warrant, and an updated Filing Fee Table.
Summary
- Encore Medical, Inc. has filed an amendment (Amendment No. 4) to its Form S-1 Registration Statement (File No. 333-290244).
- This amendment is an exhibit-only filing, adding Exhibit 4.3, which is the Form of Investor's Warrant, and an updated Filing Fee Table (Exhibit 107).
- The filing indicates that the prospectus and the remainder of Part II of the Registration Statement are unchanged.
- The company is registering common stock underlying underwriter's warrants and common stock for an initial public offering.
- The filing fee calculation shows a net fee due of $38.12, with previously paid fees totaling $2,852.26.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it is a procedural amendment to a registration statement and does not provide new operational or financial information.
Positives
- The inclusion of the Investor's Warrant form provides clarity on the terms and conditions for potential investors.
- The updated filing fee table suggests progress in the registration process.
- The company is actively managing its registration process by filing amendments.
Negatives
- The filing is an amendment and does not contain new operational or financial performance data, focusing solely on administrative and exhibit additions.
- The net fee due is minimal, which could indicate a small scale of the offering or adjustments based on previous payments.
Risks
- The Investor's Warrant is subject to securities laws and may not be sold, transferred, assigned, offered, pledged, or otherwise distributed for value unless registered or an exemption is available.
- The terms of the warrant, including the exercise price and expiration date, are not fully specified in the provided text, leaving room for interpretation.
- The registration statement is subject to becoming effective, and the proposed sale is contingent on this effectiveness.
Future Outlook
The filing is an amendment to a registration statement and does not contain specific forward-looking financial guidance. The primary forward-looking aspect relates to the proposed sale of securities upon the effectiveness of the registration statement.
Industry Context
StockSavvy.ai notes that the filing of an S-1/A amendment, particularly for adding warrant forms and updating fee tables, is a procedural step in the IPO or follow-on offering process. This is common for companies seeking to raise capital through the public markets, indicating ongoing efforts to comply with regulatory requirements.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Bylaws Amendment | Amended and Restated Bylaws of the Registrant were filed, effective February 23, 2026. | 2026-02-23 | Updates to bylaws can affect internal governance procedures and shareholder rights. |
| Articles of Incorporation Amendment | Amended and Restated Articles of Incorporation and an Amendment to the Amended and Restated Articles of Incorporation were filed, effective November 17, 2025. | 2025-11-17 | Changes to articles of incorporation can alter the fundamental structure and powers of the corporation. |
Related Party Transactions
- Convertible Promissory Note between Christopher J. Turnbull and Registrant, dated November 24, 2025.
- Convertible Promissory Note between Joseph A. Marino and Registrant, dated November 24, 2025.
- Convertible Promissory Note between 1915 Florida Investment Corp. and Registrant, dated December 10, 2025.
- Independent Contractor Agreement between Registrant and Gregory Steiner, dated December 15, 2024.
Stakeholder Impact
- Shareholders: The registration of additional securities and potential future offerings could lead to dilution.
- Investors: The terms of the Investor's Warrant and Underwriter's Warrant will impact potential returns and investment terms.
- Creditors: The company's ongoing capital raising activities may affect its debt structure and financial obligations.
Next Steps
- The Registration Statement must become effective for the proposed sale of securities to occur.
- The company will proceed with the offering as outlined in the registration statement once it is declared effective by the SEC.
Key Dates
| Date | Description |
|---|---|
| 2017-12-01 | Effective date of Bylaws of Registrant. |
| 2023-02-03 | Effective date of Commercial Lease. |
| 2023-03-03 | Effective date of First Amendment to Commercial Lease. |
| 2023-11-06 | Date of Loan Agreement and Security Agreement with Merit Medical Systems, Inc. |
| 2024-11-15 | Effective date of Contract Sales and Manufacturing Agreement between Cardia, Inc. and Registrant. |
| 2024-12-10 | Date of Convertible Promissory Note between 1915 Florida Investment Corp. and Registrant. |
| 2024-12-12 | Date of related addenda to Contract Sales and Manufacturing Agreement. |
| 2024-12-15 | Date of Independent Contractor Agreement between Registrant and Gregory Steiner. |
| 2025-02-23 | Effective date of Amended and Restated Bylaws of the Registrant. |
| 2025-05-15 | Date of Loan Agreement between Cardia, Inc. and Registrant. |
| 2025-09-01 | Date when the Company previously paid to register shares underlying the underwriter's warrant. |
| 2025-11-17 | Effective date of Amended and Restated Articles of Incorporation and Amendment to the Amended and Restated Articles of Incorporation. |
| 2025-11-24 | Date of Convertible Promissory Notes between Christopher J. Turnbull and Joseph A. Marino, and Registrant. |
| 2025-12-10 | Date of Convertible Promissory Note between 1915 Florida Investment Corp. and Registrant. |
| 2026-04-03 | Date of filing of Amendment No. 4 to Form S-1 Registration Statement. |
| 2026-04-03 | Date of signature on the Registration Statement. |
| 2029-12-31 | Placeholder for the Expiration Date of the Investor's Warrant (specific date not provided). |
Keywords
Encore Medical, S-1/A, Registration Statement, Investor's Warrant, SEC Filing, Securities Act of 1933, Filing Fee Table, Common Stock, Underwriter's Warrant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.